![]() Parla JS, Iossifov I, Grabill I, Spector MS, Kramer M, McCombie WR (2011) A comparative analysis of exome capture. Mamanova L, Coffey AJ, Scott CE, Kozarewa I, Turner EH, Kumar A, Howard E, Shendure J, Turner DJ (2010) Target-enrichment strategies for next-generation sequencing. Mertes F, ElSharawy A, Sauer S, van Helvoort JM, Van Der Zaag PJ, Franke A, Nilsson M, Lehrach H, Brookes AJ (2011) Targeted enrichment of genomic DNA regions for next-generation sequencing. Eur J Hum Genet 20:490–497īrownstein Z, Bhonker Y, Avraham KB (2012) High-throughput sequencing to decipher the genetic heterogeneity of deafness. Gilissen C, Hoischen A, Brunner HG, Veltman JA (2012) Disease gene identification strategies for exome sequencing. Genome Biol 12:228īamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J (2011) Exome sequencing as a tool for Mendelian disease gene discovery. Gilissen C, Hoischen A, Brunner HG, Veltman JA (2011) Unlocking Mendelian disease using exome sequencing. Nat Rev Genet 3:391–397ĭurbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA (2010) A map of human genome variation from population-scale sequencing. Tabor HK, Risch NJ, Myers RM (2002) Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature 461:272–276īiesecker LG, Shianna KV, Mullikin JC (2011) Exome sequencing: the expert view. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Lander ES (2011) Initial impact of the sequencing of the human genome. Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, Hua X, Ding F, Lu Y, James M, Ebben JD, Xu H, Adjei AA, Head K, Andrae JW, Tschannen MR, Jacob H, Pan J, Zhang Q, Van Den Bergh F, Xiao H, Lo KC, Patel J, Richmond T, Watt M-A, Albert T, Selzer R, Anderson M, Wang J, Wang Y, Starnes S, Yang P, You M (2012) Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ (2009) Exome sequencing identifies the cause of a mendelian disorder. Stitziel NO, Kiezun A, Sunyaev S (2011) Computational and statistical approaches to analyzing variants identified by exome sequencing. Finally, we review possible gene annotations that may help to establish a relationship between genes carrying high-priority variants and the phenotype in question, in order to identify the most likely causative mutations. ![]() We then discuss how to identify variants, and methods for first annotating detected variants using characteristics such as allele frequency, location in the genome, and predicted severity, and then classifying and prioritizing the detected variants based on those annotations. We address strategies in selecting samples to sequence, and technical considerations involved in exome sequencing. In this chapter we provide a comprehensive description of the various steps required for such an analysis. The most challenging part of using exome sequencing for the purpose of disease-causing variant detection is analyzing, interpreting, and filtering the large number of detected variants. Whole exome sequencing presents a powerful tool to study rare genetic disorders.
0 Comments
Leave a Reply. |